1. Dana-Farber Cancer Institute, Boston, MA;
2. Irmandade da Santa Casa de Misericordia de São Paulo, São Paulo, Brazil;
3. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea;
4. Ankara University School of Medicine, Ankara, Turkey;
5. National and Kapodistrian University of Athens, Athens, Greece;
6. Alexandria University, Alexandria, Egypt;
7. Medical University of Warsaw, Warsaw, Poland;
8. Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, University Hospital Schleswig-Holstein and University of Kiel, Kiel, Germany;
9. King Chulalongkorn Memorial Hospital and Chulalongkorn University, Bangkok, Thailand;
10. Siriraj Hospital, Bangkok, Thailand;
11. Chang Zheng Hospital, Shanghai, China;
12. University Hospital of Nantes, Nantes, France;
13. Winship Cancer Institute, Emory University, Atlanta, GA;
14. Department of Internal Medicine, Gachon University Gil Hospital, Incheon, Republic of Korea;
15. Medizinische Klinik und Poliklinik II, University of Würzburg, Würzburg, Germany;
16. Novartis Pharma AG, Basel, Switzerland;
17. Novartis Pharma SAS, Rueil-Malmaison, France; and
18. Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain